Dive Brief:

Pfizer on Tuesday signed a deal with the Trump administration to offer “most favored nation” drug prices to every state Medicaid program and discounted prices directly to other consumers through a new website.

The agreement also delays, by three years , any tariffs on Pfizer drugs that might arise from the ongoing “Section 232” probe into the effects of pharmaceutical imports on national security. Pfizer, which hadn’t yet joined its peers in making large U.S. production pledges , additionally vowed to spend $70 billion on “research, development and capital projects” in the next few years.

Specific terms of the deal remain “confidential,” Pfizer said. But it was announced a day after a deadline expired for big drugmakers to respond to President Trump’s call to align U

See Full Page